Dear Colleagues,
The Bio-Ontologies SIG (www.bio-ontologies.org.uk) provides a forum for
discussion of the latest and most innovative research in the application of
ontologies and more generally the organisation, presentation and
dissemination of knowledge in biomedicine and the life sciences.
Bio
Dear Friends,
The advance registration deadline for AMIA's 2011 Summit on Translational
Bioinformatics (TBI 2011; to be held March 7-9, 2011 in San Francisco) is
February 24, 2011: http://jointsummits2011.amia.org/registration
Reflecting on the unique position of translational bioinformatics in
b
It is a fascinating architecture. What particularly drew me in is the
multiple different evidence spaces they had to use. And that they made at
least a token mention to the power of utilizing structured knowledge to
enhance statistical methods.
On Tue, Feb 15, 2011 at 12:50 PM, Oliver Ruebenacke
Hello,
They reported about it on NPR morning edition:
http://www.npr.org/2011/02/14/133697585/on-jeopardy-its-man-vs-this-machine
Take care
Oliver
On Tue, Feb 15, 2011 at 11:09 AM, Michel_Dumontier
wrote:
> Given that IBM’s AI system called Watson is competing in Jeopardy ag
Here is a link to the actual show (day 1):
http://www.youtube.com/watch?annotation_id=annotation_339967&v=FXH7jn2AHAw&feature=iv
It is in two parts, there is a link to part two at the top of the video.
Fascinating!
On Feb 15, 2011, at 14:09 - 15/02/11, Michel_Dumontier wrote:
> Given that IBM’
Got a server error when I tried it, but note here's what's happening at RPI:
http://watson.rpi.edu
Chris Welty is giving a guest lecture (he's an RPI alum for all 3 of his
degrees) in the class Deborah McGuniess and I coteach, Advanced Semantic
Technologies (this afternoon).
We're all enjoying
Given that IBM's AI system called Watson is competing in Jeopardy against grand
champions, you might find the following overview of interest :
http://www.youtube.com/watch?v=3G2H3DZ8rNc
m.
Michel Dumontier
Associate Professor of Bioinformatics
Carleton University
http://dumontierlab.com
Eric,
Here is one I found : I can get you the full text if you need
it. Searching for more. does this help? C A phase 2 multiple
ascending dose trial of bapineuzumab in mild to moderate Alzheimer
disease. AU Salloway S, Sperling R, Gilman S, Fox NC, Blennow K,
Raskind M, Sabbagh M,
I apologize for possible duplications. PR
===
Dear all,
I'm glad to inform you about an initiative aiming
at coordinating the publication of a block of
papers related to biological wiki systems in the next NAR Database Issue.
This initiative is a follow-up of the NETTAB 2011
workshop on Biolo
Hi Matthias & Eric,
In that case, if could be made generic - rather than finding the specific
interaction between APOE4 and Bapineuzumab , we can retrieve a list of
biomarkers, one of which would be APOE4, that indicate suitability for
treatment with certain drugs, one of which is Bapineuzumab. Th
10 matches
Mail list logo
